CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1a/b Multicenter, Open-Label Trial to Evaluate Safety, Tolerability, and Dosimetry of LY4257496, a GRPR-Targeted Radioligand Therapy, in Adults With GRPR-Positive Advanced Solid Tumors (OMNIRAY)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07114601
Title field or adapter rule: {'original_value': 'A Phase 1a/b Multicenter, Open-Label Trial to Evaluate Safety, Tolerability, and Dosimetry of LY4257496, a GRPR-Targeted Radioligand Therapy, in Adults With GRPR-Positive Advanced Solid Tumors (OMNIRAY)', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At: 2026-10-31T23:27:30.300335+00:00
Published At: 2026-10-26T00:00:00+00:00
Record Updated At: 2026-10-26
Source Retrieved At: 2026-10-31T22:18:19.086215+00:00
Timestamp Basis: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

protocolSection.conditionsModule.conditions: ["Breast Neoplasms", "Colorectal Neoplasms", "Prostate Neoplasm", "Endometrial Neoplasms", "Neoplasm Metastasis", "Stomach Neoplasms", "Esophageal Neoplasms"]
protocolSection.statusModule.lastUpdatePostDateStruct: {"date": "2026-10-26", "type": "ACTUAL"}
protocolSection.identificationModule.nctId: "NCT07114601"
protocolSection.identificationModule.officialTitle: "A Phase 1a/b Multicenter, Open-Label Trial to Evaluate Safety, Tolerability, and Dosimetry of LY4257496, a GRPR-Targeted Radioligand Therapy, in Adults With GRPR-Positive Advanced Solid Tumors (OMNIRAY)"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct: null

{'armGroupLabels': ['LY4257496 + Standard of Care Phase 1b Cohort B', 'LY4257496 Phase 1a Dose Escalation (Cohort A1)', 'LY4257496 Phase 1a Dose Optimization (Cohort A2)', 'LY4257496 Phase 1b Cohort C', 'LY4257496 Phase 1b Cohort D'], 'description': 'Administered IV', 'name': 'LY4257496', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['LY4257496 + Standard of Care Phase 1b Cohort B'], 'description': 'Fulvestrant, Imlunestrant, Aromatase Inhibitors, Capecitabine, Abemaciclib', 'name': 'Standard of Care Anticancer Therapies', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['LY4257496 + Standard of Care Phase 1b Cohort B', 'LY4257496 Phase 1a Dose Escalation (Cohort A1)', 'LY4257496 Phase 1a Dose Optimization (Cohort A2)', 'LY4257496 Phase 1b Cohort C', 'LY4257496 Phase 1b Cohort D'], 'description': 'Administered IV at select sites', 'name': 'LY4257529', 'type': 'DIAGNOSTIC_TEST'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.